Use of Complementary/Alternative Medicine by Breast Cancer Survivors in Ontario: Prevalence and Perceptions

American Society of Clinical Oncology (ASCO) - Tập 18 Số 13 - Trang 2515-2521 - 2000
Heather Boon1, Moira Stewart1, Mary Ann Kennard1, Ross E. Gray1, Carol Sawka1, Judith Belle Brown1, Carol L. McWilliam1, Alan Gavin1, Ruth Anne Baron1, Dorothy Aaron1, Theresa Haines-Kamka1
1From the Centre for Studies in Family MedicineFaculty of Medicine and Dentistry, University of Western Ontario; London Regional Cancer Centre, London; and Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

Tóm tắt

PURPOSE: To determine the prevalence of use of complementary/alternative medicine (CAM) by breast cancer survivors in Ontario, Canada, and to compare the characteristics of CAM users and CAM nonusers. PATIENTS AND METHODS: A questionnaire was mailed to a random sample of Ontario women diagnosed with breast cancer in 1994 or 1995. RESULTS: The response rate was 76.3%. Overall, 66.7% of the respondents reported using CAM, most often in an attempt to boost the immune system. CAM practitioners (most commonly chiropractors, herbalists, acupuncturists, traditional Chinese medicine practitioners, and/or naturopathic practitioners) were visited by 39.4% of the respondents. In addition, 62.0% reported use of CAM products (most frequently vitamins/minerals, herbal medicines, green tea, special foods, and essiac). Almost one half of the respondents informed their physicians of their use of CAM. Multiple logistic regression analysis determined that support group attendance was the only factor significantly associated with CAM use. CONCLUSION: CAM use is common among Canadian breast cancer survivors, many of whom are discussing CAM therapy options with their physicians. Knowledge of CAM therapies is necessary for physicians and other health care practitioners to help patients make informed choices. CAM use may play a role in the positive benefits associated with support group attendance.

Từ khóa


Tài liệu tham khảo

10.1001/jama.280.18.1569

10.1016/0277-9536(93)90273-7

Brigden ML: Unproven (questionable) cancer therapies. West J Med 163:463,1995-469,

10.1111/1467-9566.ep11346886

10.3322/canjclin.42.3.181

10.7326/0003-4819-101-1-105

10.1136/bmj.309.6947.86

10.1056/NEJM199301283280406

Boon H, Brown JB, Gavin A, et al: Breast cancer survivors’ perceptions of complementary/alternative medicine (CAM): Making the decision to use or not to use. Qual Health Care 9:639,1999-653,

10.1001/jama.1984.03350210038026

Risberg T, Lund E, Wist E, et al: The use of non-proven therapy among patients treated in Norwegian oncology departments: A cross-sectional national multicentre study. Eur J Cancer 31A:1785,1995-1789,

10.1056/NEJM199906033402206

Montbriand MJ: Freedom of choice: An issue concerning alternate therapies chosen by patients with cancer. Oncol Nurs Forum 20:1195,1993-1201,

10.1016/S0959-8049(96)00504-7

10.1002/(SICI)1099-1611(199811/12)7:6<508::AID-PON376>3.0.CO;2-7

Devine EC, Westlake SK: The effects of psychoeducational care provided to adults with cancer: Meta-analysis of 116 studies. Oncol Nurs Forum 22:1369,1995-1381,

10.1037/0278-6133.14.2.101

10.1016/S0140-6736(89)91551-1

10.1016/S0738-3991(99)00058-0

Thông tin
Thông tin xuất bản

American Society of Clinical Oncology (ASCO)

Tập 18 Số 13

2515-2521

Thông tin tác giả